Published by Ken Research
Posted on October 5, 2021
3 min readLast updated: January 31, 2026
The cerebral embolic protection devices market is driven by advanced surgical techniques and healthcare investments, with North America leading in growth.
Cerebral embolic protection devices (CEPD) reduce the risk of strokes after Tran catheter aortic valve replacement (TAVR). These devices are designed to prevent debris from the intervention from getting into the cerebral vessels. These devices are generally developed to reduce the risk of Cerebrovascular accident (CVA) & silent emboli. They have been revealed to be effective in filtering debris and increasing the volume of ischemic embolic lesions, thereby decreasing the risk of CVA. These devices are mesh filters that prevent the embolic material from entering the carotid arteries. There are numerous cerebral embolic protection devices that differ in pore size, deployment location and chemical composition.
As per analysis, “Cerebral Embolic Protection Devices Market: Current Analysis and Forecast (2021-2027)” the key companies operating in the global cerebral embolic protection devices market include Keystone Heart, Boston Scientific, Edward Life sciences and among others. High torque ability, Cutting-edge design, and improved ability to capture plaque debris represent significant growth opportunities for manufacturers operating in the global Embolic Protective Devices market. Strategic mergers & acquisitions in the emerging markets with high growth potential in order to expand geographic coverage in countries with large patient populations but without adequate public services is a growing trend among the major players operating in the global.
In terms of product type, cerebral embolic protection devices market is categorized as keystone hearts triguard device, clarets sentinel system and Embrella embolic deflector. The triguard device is an involuntary system designed to bypass cerebral embolism during TAVR while allowing maximum blood flow to the brain and is the only bypass device that covers all 3 cerebral vessels. The clarets sentinel system is generally designed to capture the debris dislodged during TAVR. This system comprises of a dual filter system that is inserted through the right brachial or radial access to the left and brachiocephalic common carotid artery. Additionally, the Embrella Embolic Deflector is a special type of filter designed to deflect debris that migrates to the brain during the positioning & implantation of the TAVR valve. In addition, in terms of the end-user, market is categorized as hospitals and others.
Rise in geriatric population, followed by increase in prevalence of cardiovascular diseases, growth in health care investments and surge in adoption of advanced surgical techniques are some major factors, which are responsible for growth of the cerebral embolic protection devices market. Apart from this, certain limitations associated with each of the product types is a major hindering factor for market.
By geographic analysis, the North-America is a prevalent region in global cerebral embolic protection devices market owing to growth in healthcare infrastructure and increase in healthcare investment across the region. The Asia-Pacific and Europe regions are estimated to witness higher growth rate due to growth in adoption of newly developed products and large number of patients with cardiovascular diseases demanding low-cost products over the forecast period. It is likely that future of the global cerebral embolic protection devices market will be bright as a result of rise in demand for technologically advanced products coupled with rise in reimbursement coverage for cardiologic anomalies during the forecast period.
For More Information, refer to below link:-
Global Cerebral Embolic Protection Devices Market
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249
The article discusses the growth in the global cerebral embolic protection devices market driven by advanced surgical techniques.
North America is leading due to healthcare infrastructure growth, with Asia-Pacific and Europe also showing high growth potential.
Key players include Keystone Heart, Boston Scientific, and Edward Lifesciences.
Explore more articles in the Research Reports category
